文献速递生殖医学

寻求不孕症医疗援助患者治疗决策的驱动因素:一项系统综述

Driving factors in treatment decision-making of patients seeking medical assistance for infertility: a systematic review.
PubMed 文献 · Hum Reprod Update · 2024-01-01

该系统综述纳入20项研究(共12452例患者),评估辅助生殖技术(ART)治疗中有效性、安全性、负担、费用、以患者为中心和遗传亲子关系等因素在患者决策中的重要性。患者决策主要受有效性驱动,其次为安全性、负担、费用和以患者为中心;患者愿意用部分有效性换取更高安全性或更低负担。

要点

  • 患者ART决策主要受有效性驱动,其次为安全性、负担、费用和以患者为中心。
  • 评估安全性时,子代安全被认为比母亲安全更重要。
  • 患者愿意用部分有效性换取更高安全性、更低负担或更低费用。

核心结论

  • 患者ART治疗决策主要受有效性驱动,其次为安全性、负担、费用和以患者为中心。
  • 患者愿意用部分有效性换取更高安全性或更低负担及以患者为中心。
  • 评估安全性时子代安全比母亲安全更重要,非遗传亲子关系对决策无明确影响。

研究设计与样本

  • 系统综述检索Embase、PubMed、PsycINFO和CINAHL截至2023年11月前索引的研究。
  • 纳入13项离散选择实验、3项调查研究、3项访谈研究和1项联合分析,共12452例患者。
  • 每项研究中47%至100%的参与者为女性。
  • 采用GRADE工作组制定的评级评估偏倚风险。

主要发现

  • 有效性在12项离散选择实验中的10项(83%)被评為第一或第二重要因素,相对重要性范围为17%至63%,中位数34%(中等确定性证据)。
  • 安全性在8项评估研究中的5项(63%)被评為第一或第二重要因素,相对重要性范围为8%至35%,中位数23%(中等确定性证据)。
  • 费用在10项研究中的5项被评為第一或第二重要,相对重要性范围为5%至47%,中位数23%(中等确定性证据)。
  • 负担在10项研究中的3项(30%)被评為第一或第二重要,相对重要性范围为1%至43%,中位数13%(低确定性证据)。
  • 以患者为中心在5项研究中的1项(20%)被评為第二重要,相对重要性范围为7%至24%,中位数14%(低确定性证据)。

关键数值与推荐

  • 有效性相对重要性中位数34%(范围17%至63%),中等确定性证据。
  • 安全性相对重要性中位数23%(范围8%至35%),中等确定性证据。
  • 费用相对重要性中位数23%(范围5%至47%),中等确定性证据。
  • 负担相对重要性中位数13%(范围1%至43%),低确定性证据。
  • 以患者为中心相对重要性中位数14%(范围7%至24%),低确定性证据。

临床怎么用

  • 本综述结果可用于未来偏好研究,并帮助医疗专业人员指导患者决策及实现更以患者为中心的方法。
  • 患者愿意用部分有效性换取更高安全性或更低负担及以患者为中心。
  • 负担增加(周期取消、注射次数、就诊次数、时间)时,若获得有效性、安全性或更低费用,患者更可能接受。
  • 以患者为中心方面,信息提供和医生态度被认为最重要,其次为参与决策和同一医疗专业人员的治疗连续性。

局限性

  • 研究间问卷和方法学存在异质性。
  • 研究评估的属性数量和类型存在差异。
  • 偏倚风险评估为中度至高度:关键6项研究、严重4项研究、中度9项研究、低度1项研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: ART differs in effectiveness, side-effects, administration, and costs. To improve the decision-making process, we need to understand what factors patients consider to be most important. OBJECTIVE AND RATIONALE: We conducted this systematic review to assess which aspects of ART treatment (effectiveness, safety, burden, costs, patient-centeredness, and genetic parenthood) are most important in the decision-making of patients with an unfulfilled wish to have a child. SEARCH METHODS: We searched studies indexed in Embase, PubMed, PsycINFO, and CINAHL prior to November 2023. Discrete choice experiments (DCEs), surveys, interviews, and conjoint analyses (CAs) about ART were included. Studies were included if they described two or more of the following attributes: effectiveness, safety, burden, costs, patient-centeredness, and genetic parenthood.Participants were men and women with an unfulfilled wish to have a child. From each DCE/CA study, we extracted the beta-coefficients and calculated the relative importance of treatment attributes or, in case of survey studies, extracted results. We assessed the risk of bias using the rating developed by the Grading of Recommendations Assessment, Development and Evaluation working group. Attributes were classified into effectiveness, safety, burden, costs, patient-centeredness, genetic parenthood, and others. OUTCOMES: The search identified 938 studies of which 20 were included: 13 DCEs, three survey studies, three interview studies, and one conjoint analysis, with a total of 12 452 patients. Per study, 47-100% of the participants were women. Studies were assessed as having moderate to high risk of bias (critical: six studies, serious: four studies, moderate: nine studies, low: one study). The main limitation was the heterogeneity in the questionnaires and methodology utilized. Studies varied in the number and types of assessed attributes. Patients' treatment decision-making was mostly driven by effectiveness, followed by safety, burden, costs, and patient-centeredness. Effectiveness was rated as the first or second most important factor in 10 of the 12 DCE studies (83%) and the relative importance of effectiveness varied between 17% and 63%, with a median of 34% (moderate certainty of evidence). Of eight studies evaluating safety, five studies valued safety as the first or second most important factor (63%), and the relative importance ranged from 8% to 35% (median 23%) (moderate certainty of evidence). Cost was rated as first or second most important in five of 10 studies, and the importance relative to the other attributes varied between 5% and 47% (median 23%) (moderate certainty of evidence). Burden was rated as first or second by three of 10 studies (30%) and the relative importance varied between 1% and 43% (median 13%) (low certainty of evidence). Patient-centeredness was second most important in one of five studies (20%) and had a relative importance between 7% and 24% (median 14%) (low certainty of evidence). Results suggest that patients are prepared to trade-off some effectiveness for more safety, or less burden and patient-centeredness. When safety was evaluated, the safety of the child was considered more important than the mother's safety. Greater burden (cycle cancellations, number of injections, number of hospital visits, time) was more likely to be accepted by patients if they gained effectiveness, safety, or lower costs. Concerning patient-centeredness, information provision and physician attitude were considered most important, followed by involvement in decision-making, and treatment continuity by the same medical professional. Non-genetic parenthood did not have a clear impact on decision-making. WIDER IMPLICATIONS: The findings of this review can be used in future preference studies and can help healthcare professionals in guiding patients' decision-making and enable a more patient-centered approach.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. von Estorff F, Mochtar MH, Lehmann V, et al. Driving factors in treatment decision-making of patients seeking medical assistance for infertility: a systematic review. Hum Reprod Update. 2024. PMID: 38305635. doi:10.1093/humupd/dmae001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。